1. IPTG in New Research: sRNAS & Alternative Inducers (2016)

    IPTG in New Research: sRNAS & Alternative Inducers (2016)
    IPTG mimics allolactase, a lac operon inducer, and is commonly used in scientific research to create proteins. It does not break down as allolactase would, keeping protein creation in steady production depending on IPTG concentration. Below are recent scientific articles that highlight some IPTG's applications in current research, and some of the future of its use. Novel sRNAS in E. coli Who: Geunu...
  2. Cancer Treatment Combination of Paclitaxel, Rapamycin and 17-AAG

    The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a composition of the synergistic anticancer agents rapamycin, paclitaxel and 17-AAG, encapsulated and solubilized by nontoxic, nanoscale PEG-b-PLA micelles.
  3. Paclitaxel - A Mitotic Inhibitor Used in Cancer Chemotherapy

    Paclitaxel, Taxus brevifolia, commonly known as the Pacific yew, is a member of the yew family (Taxaceae). It is a small, slow growing evergreen tree native to the northwestern United States (Wheeler et al., 1992).
  4. Sonic Hedgehog Signaling Pathway

    Activation of the hedgehog pathway has been implicated in the development of cancers in various organs, including brain, lung, mammary gland, prostate and skin. Basal cell carcinoma, the most common form of cancerous malignancy, has the closest association with hedgehog signaling.

4 Item(s)

To Top